NEW YORK: Novartis said on Wednesday the two top research & development executives at its Avexis unit were no longer at the company after some data from early testing of Avexis's more than US$2-million gene therapy Zolgensma was manipulated.
The U.S. Food and Drug Administration said last week that Novartis had notified regulators in June - more than a month after Zolgensma had been approved - that some of the early testing data had been manipulated.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Trump says US learning ‘much’ from Russian missile test blastWASHINGTON President Donald Trump said on Monday that the US is learning 'much' from a deadly blast during a Russian missile test that caused elevated radiation levels. 'The United States is learning much from the failed missile explosion in Russia. We have similar, though...
Source: thenewpaper - 🏆 7. / 63 Read more »
Source: YahooSG - 🏆 3. / 71 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »